Physician profile
David S Oliver
NPI 1922000959
$4,900.74
in general payments reported to CMS, 2019-2025
20 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Otolaryngic Allergy provider received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,222 · 2020: $443 · 2021: $686 · 2022: $551 · 2023: $272 · 2024: $267 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,816.34 | 2019-2025 | Latera |
| Inspire Medical Systems, INC. | $616.90 | 2019-2025 | Inspire |
| Optinose US, INC. | $411.03 | 2019-2025 | |
| Glaxosmithkline, LLC. | $347.58 | 2021-2025 | Nucala |
| Alk-Abello, INC | $258.31 | 2019-2022 | |
| Genzyme Corporation | $250.60 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $250.05 | 2020-2025 | Dupixent |
| Acclarent, INC | $244.54 | 2019-2022 | |
| Intersect Ent, INC. | $210.34 | 2019-2021 | |
| Aerin Medical INC. | $143.88 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $102.94 | 2019 | |
| Integra Lifesciences Corporation | $59.43 | 2020-2025 | Codman Isocool Aht, Integra Duo, Instruments-Orthopedic |
| Smith+Nephew, INC. | $35.17 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $31.98 | 2024-2025 | Ryaltris |
| Organogenesis INC. | $31.82 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $20.56 | 2020 | |
| Amgen INC. | $19.59 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $19.21 | 2025 | Neffy |
| Axogen | $17.28 | 2019 | |
| Medtronic, INC. | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.